OCRA has invested $110 million in innovative ovarian cancer research — more than any other charity in the world. The good news is, the science is working: new treatments are saving lives, and the next breakthrough could be right around the corner.
But we still have much further to go. Despite extraordinary progress, ovarian cancer remains the number one cause of gynecologic cancer deaths. We must continue to drive research forward, and raise awareness of the risk factors and symptoms of this disease.
This September, we need you to step up and make a difference. Everyone has something to give, and every action brings us closer to a world where no one needs to fear an ovarian cancer diagnosis.
Whether you make a donation or rally your friends for a feel-good fundraiser, there’s nothing more heroic than stepping up for those who are counting on us.
- Every dollar counts in this fight, and we need your help in reaching our $230,000 goal. As we speak, 230,000 patients and loved ones across the country are counting on us. Make your Ovarian Cancer Awareness Month donation today, and be part of the cure.
- Increase your support by making a personal fundraising page or Facebook fundraiser, host an event, or attend one near you. The possibilities are endless, and we’re here to help you with any ideas you have. Start here, or email us with questions on next steps.
Are you a passionate advocate for the cause? A social media superstar? Do you want to make sure all your friends and loved ones are aware of the risk factors and symptoms? We need you!
- Today, re-authorization of Johanna’s Law hangs in the balance. Sign OCRA’s Action Alert to ensure the reauthorization of Johanna’s Law, which supports a variety of programs, research projects and activities at Centers for Disease Control and Prevention (CDC) aimed at educating healthcare providers and the general population alike.
- Spread the word on social media! Check out our Ovarian Cancer Awareness Month toolkit to grab some informational and attention-grabbing graphics to share.